SRPK2 and COVID-19: CST5 (adjusted fold change (FC)=0.065, p value<0.001), SRPK2 (adjusted FC=0.664, p value=0.003) and TGF-α (adjusted FC=0.647, p value=0.026) showed lower levels in COVID-19 patients.